Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Chemphys Placement Participation Funds Received

by admin January 28, 2025
January 28, 2025
Chemphys Placement Participation Funds Received

Galan Lithium Limited (ASX: GLN) (Galan or the Company) is pleased to advise that it has received proceeds from Latam Resources Pty Limited (Latam), an Affiliate of Chengdu Chemphys Chemical Industry Co., Ltd (Chemphys) in relation to the share placement (Placement) announced by the Company on 10 September 2024 and subsequently approved by shareholders at the Galan Annual General Meeting held on 15 November 2024. Chemphys agreed to subscribe for US$3 million worth of shares under the terms of the Placement.

Funds received from Latam will be applied by Galan towards ongoing Phase 1 operations at Hombre Muerto West (HMW), as parties continue to work towards finalising an offtake prepayment facility targeted financial close during the first quarter of 2025.

Click here for the full ASX Release

This post appeared first on investingnews.com

previous post
Growth-Focused Gold Explorer: Torque Metals and Aston Minerals Unite in Strategic Merger
next post
Newmont Completes Divestitures With US$425 Million Sale to Discovery Silver

Related Posts

Don Durrett: Gold, Silver Price Targets and 15...

February 8, 2025

Canadian Investment Regulatory Organization Trade Resumption – WCU

February 20, 2025

Questcorp Mining Announces Private Placement

September 26, 2025

Crypto Market Recap: UAE Readies Digital Dirham CBDC,...

March 29, 2025

Andy Schectman: BRICS, Trump and Gold — What...

February 6, 2025

RCM to Acquire Webbs Consol Silver Project from...

September 1, 2025

Uranium Price Forecast: Top Trends for Uranium in...

December 15, 2025

American Lithium Takes Stake in Golden Triangle Gold...

January 21, 2026

BPH Energy LimitedRaises $1.2M to Accelerate Funding of...

January 12, 2026

Altech – Service Data Confirms Exceptional Failure Rate

November 6, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved